These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8960661)

  • 1. [Three cases of secondary acute myeloid leukemia after long-term treatment with oral etoposide].
    Kikuta T; Shimazaki C; Hirai H; Sumikuma T; Sudo Y; Yamagata N; Ashihara E; Goto H; Inaba T; Fujita N; Hatta T; Nakagawa M
    Rinsho Ketsueki; 1996 Nov; 37(11):1276-82. PubMed ID: 8960661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Successful treatment with G-CSF and continuous infusion of low-dose cytarabine and etoposide for therapy-related acute myeloid leukemia developed during chemotherapy for malignant lymphoma].
    Yamamoto K; Nagata K; Morita Y; Hamaguchi H
    Rinsho Ketsueki; 2002 Jun; 43(6):488-92. PubMed ID: 12134707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary leukemia in a child with neuroblastoma while on oral etoposide: what is the cause?
    Ng A; Taylor GM; Eden OB
    Pediatr Hematol Oncol; 2000; 17(3):273-9. PubMed ID: 10779995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myelomonocytic leukemia after treatment with chronic oral etoposide: are MLL and LTG9 genes targets for etoposide?
    Goto H; Shimazaki C; Tatsumi T; Yamagata N; Inaba T; Fujita N; Moriguchi T; Yamamoto K; Seto M; Ueda R
    Int J Hematol; 1994 Aug; 60(2):145-9. PubMed ID: 7948964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term oral administration of etoposide in the treatment of patients with advanced non-small-cell carcinoma of the lung. The second phase of a clinical study].
    Jeremić B; Djurić Lj; Jevremović S; Stefanović K; Matović M
    Srp Arh Celok Lek; 1996; 124(3-4):65-8. PubMed ID: 9102821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Small cell lung cancer with acute monocytic leukemia after combined chemotherapy including etoposide].
    Tamada T; Kimura K; Tabata M; Ishimori S; Tsuburaya T; Hayashi M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 May; 35(5):577-82. PubMed ID: 9234639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.
    Josting A; Wiedenmann S; Franklin J; May M; Sieber M; Wolf J; Engert A; Diehl V;
    J Clin Oncol; 2003 Sep; 21(18):3440-6. PubMed ID: 12668650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary acute myeloid leukemia following treatment with VP16-containing regimens for non-Hodgkin's lymphoma.
    Orlandi E; Lazzarino M; Bernasconi P; Astori C; Bernasconi C
    Haematologica; 1998 Aug; 83(8):758-9. PubMed ID: 9793267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy-related acute myeloid leukemia with 11q23 abnormality due to paclitaxel coexisting with bone marrow metastasis of breast cancer].
    Saito M; Mori A; Irie T; Tanaka M; Morioka M
    Rinsho Ketsueki; 2009 Mar; 50(3):192-6. PubMed ID: 19352087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.
    RamaChandran S; Ariffin H
    Pediatr Blood Cancer; 2009 Sep; 53(3):488-90. PubMed ID: 19434733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary acute myelogenous leukemia following safe exposure to etoposide.
    Stine KC; Saylors RL; Sawyer JR; Becton DL
    J Clin Oncol; 1997 Apr; 15(4):1583-6. PubMed ID: 9193356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
    Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
    Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacology of chronic oral etoposide in patients with small cell and non-small cell lung cancer.
    Zucchetti M; Pagani O; Torri V; Sessa C; D'Incalci M; De Fusco M; de Jong J; Gentili D; Martinelli G; Tinazzi A
    Clin Cancer Res; 1995 Dec; 1(12):1517-24. PubMed ID: 9815952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary study of efficacy of intravenous cisplatin plus oral etoposide in small cell lung cancer.
    Chewaskulyong B; Thongprasert S
    J Med Assoc Thai; 1998 Jan; 81(1):37-41. PubMed ID: 9470320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation.
    Sobecks RM; Le Beau MM; Anastasi J; Williams SF
    Bone Marrow Transplant; 1999 Jun; 23(11):1161-5. PubMed ID: 10382956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prolonged oral etoposide therapy in advanced stage lung cancer].
    Bozóky G; Ruby E; Góhér I; Mohos A; Lengyel M
    Orv Hetil; 1997 Jul; 138(28):1791-5. PubMed ID: 9280873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
    Ogasawara T; Yasuyama M; Kawauchi K
    Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphoma.
    Howe R; Micallef IN; Inwards DJ; Ansell SM; Dewald GW; Dispenzieri A; Gastineau DA; Gertz MA; Geyer SM; Hanson CA; Lacy MQ; Tefferi A; Litzow MR
    Bone Marrow Transplant; 2003 Aug; 32(3):317-24. PubMed ID: 12858205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary acute myelogenous leukemia following treatment with oral etoposide.
    Katato K; Flaherty L; Varterasian M
    Am J Hematol; 1996 Sep; 53(1):54-5. PubMed ID: 8813107
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy-related acute myeloid leukemia following double autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma].
    Fujii H; Iwai T; Ueda Y; Nakagawa H
    Rinsho Ketsueki; 2002 Jun; 43(6):482-7. PubMed ID: 12134706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.